Re:Common prostate cancer treatment linked to later dementia...
by chmaynard on Friday October 14, 2016 @10:58AM
(#12708474)
> Leuprolide, goserelin, triptorelin, histrelin, Degarelix, flutamide, bicalutamide, nilutamide, Enzalutamide, Cyproterone acetate, Lupron, Zoladex, Trelstar, Vantas, Firmagon, Eulexin, Casodex, Nilandron, Xtandi, Nizoral, Androcur, Eligard, Cyprostat, Anandron, Flutamin, Cytomid, Cosudex, Calutide, Kalumid
The number of medications in this list (29) is rather striking. Assuming the FDA approved all of these drugs to treat a single condition, this treatment must be VERY profitable!
Re:Common prostate cancer treatment linked to later dementia...
by slyrus on Friday October 14, 2016 @12:35PM
(#12709211)
It's annoying how the press release manages to have links for the institutions involved, the authors, various initiatives and departments, but not for the paper itself. Surely encouraging folks to read the work should be as important as trumpeting the fact that the work was done.
Leuprolide, goserelin, triptorelin, histrelin, Degarelix, flutamide, bicalutamide, nilutamide, Enzalutamide, Cyproterone acetate, Lupron, Zoladex, Trelstar, Vantas, Firmagon, Eulexin, Casodex, Nilandron, Xtandi, Nizoral, Androcur, Eligard, Cyprostat, Anandron, Flutamin, Cytomid, Cosudex, Calutide, Kalumid
So relax, finasteride does not seem to be on the list.
[1] http://jamanetwork.com/journals/jamaoncology/fullarticle/256... (probably paywalled)